86 related articles for article (PubMed ID: 19863170)
1. MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?
Diepstra A
Leuk Lymphoma; 2009 Nov; 50(11):1740-1. PubMed ID: 19863170
[No Abstract] [Full Text] [Related]
2. Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.
Wilkinson ST; Fernandez DR; Murphy SP; Braziel RM; Campo E; Chan WC; Delabie J; Gascoyne RD; Staudt LM; Jaffe ES; Rosenwald A; Rimsza LM
Leuk Lymphoma; 2009 Nov; 50(11):1875-8. PubMed ID: 19814686
[No Abstract] [Full Text] [Related]
3. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
4. DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
Murphy SP; Holtz R; Lewandowski N; Tomasi TB; Fuji H
J Immunol; 2002 Sep; 169(6):3085-93. PubMed ID: 12218125
[TBL] [Abstract][Full Text] [Related]
5. CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.
Rimsza LM; Chan WC; Gascoyne RD; Campo E; Jaffe ES; Staudt LM; Delabie J; Rosenwald A; Murphy SP
Haematologica; 2009 Apr; 94(4):596-8. PubMed ID: 19229048
[No Abstract] [Full Text] [Related]
6. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.
Roberts RA; Wright G; Rosenwald AR; Jaramillo MA; Grogan TM; Miller TP; Frutiger Y; Chan WC; Gascoyne RD; Ott G; Muller-Hermelink HK; Staudt LM; Rimsza LM
Blood; 2006 Jul; 108(1):311-8. PubMed ID: 16543468
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
[TBL] [Abstract][Full Text] [Related]
8. Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression.
Mottok A; Woolcock B; Chan FC; Tong KM; Chong L; Farinha P; Telenius A; Chavez E; Ramchandani S; Drake M; Boyle M; Ben-Neriah S; Scott DW; Rimsza LM; Siebert R; Gascoyne RD; Steidl C
Cell Rep; 2015 Nov; 13(7):1418-1431. PubMed ID: 26549456
[TBL] [Abstract][Full Text] [Related]
9. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
[TBL] [Abstract][Full Text] [Related]
10. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
11. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
12. Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region.
Schooten E; Klous P; van den Elsen PJ; Holling TM
Immunogenetics; 2005 Nov; 57(10):795-9. PubMed ID: 16235089
[TBL] [Abstract][Full Text] [Related]
13. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
[TBL] [Abstract][Full Text] [Related]
14. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
16. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
[TBL] [Abstract][Full Text] [Related]
18. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
20. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
